Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome

Journal of Molecular and Cellular Cardiology

Volumn 101, Issue , 2016, Pages 165-172

  Chiang, David Y ^a,b,c   Heck, Albert J R ^b   Dobrev, Dobromir ^d   Wehrens, Xander H T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Atrial fibrillation; Heart failure; Protein phosphatase; Proteomics; Regulatory subunit

Indexed keywords

PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 CATALYTIC SUBUNIT; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG; CARRIER PROTEIN; PROTEIN BINDING;

AFFINITY PURIFICATION MASS SPECTROMETRY; ARTICLE; ATRIAL FIBRILLATION; BIOINFORMATICS; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; BIOLOGY; CARDIAC MUSCLE; HEART; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN ANALYSIS;

ANIMALS; ATRIAL FIBRILLATION; CARRIER PROTEINS; COMPUTATIONAL BIOLOGY; HEART; HEART FAILURE; HUMANS; MYOCARDIUM; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN PHOSPHATASE 1;

EID: 84995920292     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.09.009     Document Type: Article

References (56)

1. [1] Shi, Y., Serine/threonine phosphatases: mechanism through structure. Cell 139 (2009), 468–484.
2. [2] Ceulemans, H., Bollen, M., Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84 (2004), 1–39.
3. [3] Heroes, E., Lesage, B., Gornemann, J., Beullens, M., Van Meervelt, L., Bollen, M., The PP1 binding code: a molecular-lego strategy that governs specificity. FEBS J. 280 (2013), 584–595.
4. + current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110 (2004), 2651–2657.
5. + handling in human chronic atrial fibrillation. Circulation 114 (2006), 670–680.
6. [6] Heijman, J., Dewenter, M., El-Armouche, A., Dobrev, D., Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. J. Mol. Cell. Cardiol. 64 (2013), 90–98.
7. [7] Greiser, M., Halaszovich, C.R., Frechen, D., Boknik, P., Ravens, U., Dobrev, D., et al. Pharmacological evidence for altered src kinase regulation of I (Ca, L) in patients with chronic atrial fibrillation. Naunyn Schmiedeberg's Arch. Pharmacol. 375 (2007), 383–392.
8. + leak promotes atrial fibrillation in mice. J. Clin. Invest. 119 (2009), 1940–1951.
9. [9] Chiang, D.Y., Lebesgue, N., Beavers, D.L., Alsina, K.M., Damen, J.M., Voigt, N., et al. Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. J. Am. Coll. Cardiol. 65 (2015), 163–173.
10. [10] Voigt, N., Heijman, J., Wang, Q., Chiang, D.Y., Li, N., Karck, M., et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129 (2013), 145–156.
11. [11] Greiser, M., Neuberger, H.R., Harks, E., El-Armouche, A., Boknik, P., de Haan, S., et al. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J. Mol. Cell. Cardiol. 46 (2009), 385–394.
12. [12] Yeh, Y.H., Wakili, R., Qi, X.Y., Chartier, D., Boknik, P., Kaab, S., et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ. Arrhythm Electrophysiol. 1 (2008), 93–102.
13. [13] Wakili, R., Yeh, Y.H., Yan Qi, X., Greiser, M., Chartier, D., Nishida, K., et al. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ. Arrhythm Electrophysiol. 3 (2010), 530–541.
14. + signaling in atrial myocytes. J. Clin. Invest. 124 (2014), 4759–4772.
15. [15] Li, N., Chiang, D.Y., Wang, S., Wang, Q., Sun, L., Voigt, N., et al. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 129 (2014), 1276–1285.
16. [16] Marx, S.O., Reiken, S., Hisamatsu, Y., Gaburjakova, M., Gaburjakova, J., Yang, Y.M., et al. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J. Cell Biol. 153 (2001), 699–708.
17. [17] Chiang, D.Y., Li, N., Wang, Q., Alsina, K.M., Quick, A.P., Reynolds, J.O., et al. Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. Cardiovasc. Res. 103 (2014), 178–187.
18. [18] Neumann, J., Eschenhagen, T., Jones, L.R., Linck, B., Schmitz, W., Scholz, H., et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29 (1997), 265–272.
19. [19] Huang, B., Wang, S., Qin, D., Boutjdir, M., El-Sherif, N., Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. Circ. Res. 85 (1999), 848–855.
20. [20] Schwoerer, A.P., Neuber, C., Schmechel, A., Melnychenko, I., Mearini, G., Boknik, P., et al. Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance. J. Mol. Cell. Cardiol. 45 (2008), 846–852.
21. [21] El-Armouche, A., Pamminger, T., Ditz, D., Zolk, O., Eschenhagen, T., Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc. Res. 61 (2004), 87–93.
22. [22] Gupta, R.C., Mishra, S., Rastogi, S., Imai, M., Habib, O., Sabbah, H.N., Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts. Am. J. Physiol. Heart Circ. Physiol. 285 (2003), H2373–H2381.
23. [23] Respress, J.L., van Oort, R.J., Li, N., Rolim, N., Dixit, S.S., deAlmeida, A., et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110 (2012), 1474–1483.
24. [24] Carr, A.N., Schmidt, A.G., Suzuki, Y., del Monte, F., Sato, Y., Lanner, C., et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22 (2002), 4124–4135.
25. [25] Pathak, A., del Monte, F., Zhao, W., Schultz, J.E., Lorenz, J.N., Bodi, I., et al. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ. Res. 96 (2005), 756–766.
26. [26] El-Armouche, A., Wittkopper, K., Degenhardt, F., Weinberger, F., Didie, M., Melnychenko, I., et al. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 80 (2008), 396–406.
27. [27] Wittkopper, K., Fabritz, L., Neef, S., Ort, K.R., Grefe, C., Unsold, B., et al. Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J. Clin. Invest. 120 (2010), 617–626.
28. [28] Kirchhefer, U., Baba, H.A., Boknik, P., Breeden, K.M., Mavila, N., Bruchert, N., et al. Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovasc. Res. 68 (2005), 98–108.
29. [29] Bruchert, N., Mavila, N., Boknik, P., Baba, H.A., Fabritz, L., Gergs, U., et al. Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H1539–H1546.
30. [30] Grote-Wessels, S., Baba, H.A., Boknik, P., El-Armouche, A., Fabritz, L., Gillmann, H.J., et al. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload. Cardiovasc. Res. 79 (2008), 464–471.
31. [31] Nicolaou, P., Rodriguez, P., Ren, X., Zhou, X., Qian, J., Sadayappan, S., et al. Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circ. Res. 104 (2009), 1012–1020.
32. [32] Ladilov, Y., Maxeiner, H., Wolf, C., Schafer, C., Meuter, K., Piper, H.M., Role of protein phosphatases in hypoxic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1092–H1098.
33. [33] Egloff, M.P., Johnson, D.F., Moorhead, G., Cohen, P.T., Cohen, P., Barford, D., Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J. 16 (1997), 1876–1887.
34. [34] Wakula, P., Beullens, M., Ceulemans, H., Stalmans, W., Bollen, M., Degeneracy and function of the ubiquitous RVXF motif that mediates binding to protein phosphatase-1. J. Biol. Chem. 278 (2003), 18817–18823.
35. [35] Ceulemans, H., Bollen, M., A tighter RVxF motif makes a finer sift. Chem. Biol. 13 (2006), 6–8.
36. [36] Meiselbach, H., Sticht, H., Enz, R., Structural analysis of the protein phosphatase 1 docking motif: molecular description of binding specificities identifies interacting proteins. Chem. Biol. 13 (2006), 49–59.
37. [37] Hendrickx, A., Beullens, M., Ceulemans, H., Den Abt, T., Van Eynde, A., Nicolaescu, E., et al. Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem. Biol. 16 (2009), 365–371.
38. [38] Silva, J.V., Freitas, M.J., Felgueiras, J., Fardilha, M., The power of the yeast two-hybrid system in the identification of novel drug targets: building and modulating PPP1 interactomes. Expert Rev. Proteomics 12 (2015), 147–158.
39. [39] Bennett, D., Lyulcheva, E., Alphey, L., Hawcroft, G., Towards a comprehensive analysis of the protein phosphatase 1 interactome in Drosophila. J. Mol. Biol. 364 (2006), 196–212.
40. [40] Esteves, S.L., Domingues, S.C., da Cruz e Silva, O.A., Fardilha, M., da Cruz e Silva, E.F., Protein phosphatase 1alpha interacting proteins in the human brain. OMICS 16 (2012), 3–17.
41. [41] Esteves, S.L., Korrodi-Gregorio, L., Cotrim, C.Z., van Kleeff, P.J., Domingues, S.C., da Cruz e Silva, O.A., et al. Protein phosphatase 1gamma isoforms linked interactions in the brain. J. Mol. Neurosci. 50 (2013), 179–197.
42. [42] Fardilha, M., Esteves, S.L., Korrodi-Gregorio, L., Vintem, A.P., Domingues, S.C., Rebelo, S., et al. Identification of the human testis protein phosphatase 1 interactome. Biochem. Pharmacol. 82 (2011), 1403–1415.
43. [43] Hrabchak, C., Varmuza, S., Identification of the spermatogenic zip protein Spz1 as a putative protein phosphatase-1 (PP1) regulatory protein that specifically binds the PP1cgamma2 splice variant in mouse testis. J. Biol. Chem. 279 (2004), 37079–37086.
44. [44] Hrabchak, C., Henderson, H., Varmuza, S., A testis specific isoform of endophilin B1, endophilin B1t, interacts specifically with protein phosphatase-1c gamma2 in mouse testis and is abnormally expressed in PP1c gamma null mice. Biochemistry 46 (2007), 4635–4644.
45. [45] Kao, S.C., Chen, C.Y., Wang, S.L., Yang, J.J., Hung, W.C., Chen, Y.C., et al. Identification of phostensin, a PP1 F-actin cytoskeleton targeting subunit. Biochem. Biophys. Res. Commun. 356 (2007), 594–598.
46. [46] Chen, C.Y., Lai, N.S., Yang, J.J., Huang, H.L., Hung, W.C., Li, C., et al. FLJ23654 encodes a heart protein phosphatase 1-binding protein (Hepp1). Biochem. Biophys. Res. Commun. 391 (2010), 698–702.
47. [47] Walsh, E.P., Lamont, D.J., Beattie, K.A., Stark, M.J., Novel interactions of Saccharomyces cerevisiae type 1 protein phosphatase identified by single-step affinity purification and mass spectrometry. Biochemistry 41 (2002), 2409–2420.
48. [48] Trinkle-Mulcahy, L., Andersen, J., Lam, Y.W., Moorhead, G., Mann, M., Lamond, A.I., Repo-man recruits PP1 gamma to chromatin and is essential for cell viability. J. Cell Biol. 172 (2006), 679–692.
49. [49] Moorhead, G.B., Trinkle-Mulcahy, L., Nimick, M., De Wever, V., Campbell, D.G., Gourlay, R., et al. Displacement affinity chromatography of protein phosphatase one (PP1) complexes. BMC Biochem., 9, 2008, 28.
50. [50] Templeton, G.W., Nimick, M., Morrice, N., Campbell, D., Goudreault, M., Gingras, A.C., et al. Identification and characterization of AtI-2, an Arabidopsis homologue of an ancient protein phosphatase 1 (PP1) regulatory subunit. Biochem. J. 435 (2011), 73–83.
51. [51] MacLeod, G., Varmuza, S., Tandem affinity purification in transgenic mouse embryonic stem cells identifies DDOST as a novel PPP1CC2 interacting protein. Biochemistry 51 (2012), 9678–9688.
52. [52] Cid, C., Garcia-Bonilla, L., Camafeita, E., Burda, J., Salinas, M., Alcazar, A., Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance. Proteomics 7 (2007), 3207–3218.
53. [53] Hollin, T., De Witte, C., Lenne, A., Pierrot, C., Khalife, J., Analysis of the interactome of the Ser/Thr protein phosphatase type 1 in plasmodium falciparum. BMC Genomics, 17, 2016, 246.
54. [54] Tsaytler, P., Harding, H.P., Ron, D., Bertolotti, A., Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332 (2011), 91–94.
55. +) cycling. Cardiovasc. Res. 89 (2011), 79–88.
56. [56] Liu, R., Correll, R.N., Davis, J., Vagnozzi, R.J., York, A.J., Sargent, M.A., et al. Cardiac-specific deletion of protein phosphatase 1beta promotes increased myofilament protein phosphorylation and contractile alterations. J. Mol. Cell. Cardiol. 87 (2015), 204–213.